HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Dréno Selected Research

diacneal

1/2005Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Dréno Research Topics

Disease

27Acne Vulgaris
06/2022 - 02/2001
12Melanoma (Melanoma, Malignant)
09/2021 - 05/2001
7Neoplasms (Cancer)
09/2021 - 05/2001
5Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2015 - 05/2001
4Neoplasm Metastasis (Metastasis)
09/2021 - 12/2008
4Skin Neoplasms (Skin Cancer)
07/2021 - 03/2007
4Basal Cell Carcinoma (Rodent Ulcer)
09/2020 - 05/2015
3Skin Diseases (Skin Disease)
07/2021 - 10/2011
3Psoriasis (Pustulosis Palmaris et Plantaris)
02/2019 - 05/2001
3Inflammation (Inflammations)
09/2017 - 10/2011
3Parapsoriasis
04/2014 - 05/2001
2Exanthema (Rash)
01/2021 - 01/2017
2Dermatitis
01/2021 - 05/2001
2Granuloma
06/2020 - 01/2004
2Sarcoidosis (Schaumann Disease)
06/2020 - 01/2004
2Telangiectasis (Telangiectasia)
01/2019 - 04/2018
2Mental Disorders (Mental Disorder)
01/2018 - 04/2007
2Necrosis
09/2017 - 12/2008
2Folliculitis (Sycosis)
10/2011 - 03/2002
1Bullous Pemphigoid (Pemphigoid)
08/2021
1Hypertension (High Blood Pressure)
01/2021
1Diarrhea
01/2021
1Actinic Keratosis
10/2020
1Pathologic Complete Response
10/2020
1Hypersensitivity (Allergy)
06/2020
1Peanut Hypersensitivity (Peanut Allergy)
09/2018
1Pigmentation Disorders (Ito Syndrome)
04/2018
1Atrophy
04/2018
1Hemangiosarcoma (Angiosarcoma)
02/2018
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018
1Spasm (Spasms)
11/2017
1Facial Pain (Myofacial Pain)
09/2017
1Headache (Headaches)
09/2017
1Fever (Fevers)
01/2017

Drug/Important Bio-Agent (IBA)

8Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 02/2001
8Isotretinoin (Accutane)FDA LinkGeneric
09/2018 - 01/2006
6RetinoidsIBA
01/2018 - 01/2005
4HhAntag691IBA
09/2020 - 05/2015
4Benzoyl PeroxideFDA LinkGeneric
10/2017 - 01/2005
4SaltsIBA
10/2011 - 03/2002
4CytokinesIBA
12/2008 - 05/2001
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2021 - 01/2017
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2021 - 01/2017
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2017
3CosmeticsIBA
12/2017 - 02/2011
3VemurafenibIBA
01/2017 - 10/2014
3Pharmaceutical PreparationsIBA
09/2016 - 04/2007
2pembrolizumabIBA
09/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2017
2cobimetinibIBA
01/2021 - 01/2017
2ParaffinIBA
02/2019 - 05/2001
2Formaldehyde (Formol)FDA Link
02/2019 - 05/2001
2Propranolol (Inderal)FDA LinkGeneric
01/2019 - 02/2018
2Erythromycin (Erycette)FDA LinkGeneric
06/2018 - 03/2010
2Adapalene (Differin)FDA LinkGeneric
10/2017 - 08/2011
2InterferonsIBA
09/2017 - 12/2008
2InterleukinsIBA
09/2017 - 05/2001
2azelaic acid (Azelex)FDA Link
09/2016 - 02/2011
2ErbB Receptors (EGF Receptor)IBA
04/2013 - 05/2012
2Infliximab (Remicade)FDA Link
01/2013 - 08/2012
2ZincIBA
10/2011 - 01/2008
2AntigensIBA
10/2010 - 12/2003
2gluconic acid (gluconate)FDA LinkGeneric
01/2008 - 04/2007
2Interferon-alpha (Interferon Alfa)IBA
09/2005 - 01/2004
1QuinolonesIBA
03/2022
1NivolumabIBA
09/2021
1trametinibIBA
09/2021
1dabrafenibIBA
09/2021
1Biological ProductsIBA
08/2021
1Sunscreening Agents (Sunscreens)IBA
07/2021
1atezolizumabIBA
01/2021
1Niacinamide (Nicotinamide)FDA LinkGeneric
10/2020
1sonidegibIBA
09/2020
1SootIBA
06/2020
1Azathioprine (Imuran)FDA LinkGeneric
05/2019
1Tacrolimus (Prograf)FDA LinkGeneric
05/2019
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2019
1AdipokinesIBA
02/2019
1Ado-Trastuzumab EmtansineIBA
01/2019
1PorphyrinsIBA
06/2018
1Clindamycin (Cleocin)FDA LinkGeneric
06/2018
1Environmental Pollutants (Pollutants, Environmental)IBA
05/2018
1Indicators and Reagents (Reagents)IBA
04/2018
1SandIBA
04/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2018
1EmollientsIBA
10/2017
1LipidsIBA
09/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2017
1Matrix Metalloproteinases (MMPs)IBA
09/2017
1Proteinase-Activated ReceptorsIBA
09/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2017

Therapy/Procedure

18Therapeutics
06/2022 - 05/2001
4Aftercare (After-Treatment)
06/2018 - 01/2006
2Immunotherapy
10/2020 - 12/2008
2Tattooing
06/2020 - 01/2004
1Activities of Daily Living (ADL)
05/2021
1Secondary Prevention
10/2020
1Investigational Therapies (Experimental Therapy)
10/2020
1Radiotherapy
04/2018
1Anesthesia
09/2017